Siegfried Holding Past Earnings Performance
Past criteria checks 2/6
Siegfried Holding has been growing earnings at an average annual rate of 25.2%, while the Life Sciences industry saw earnings growing at 19.1% annually. Revenues have been growing at an average rate of 11.8% per year. Siegfried Holding's return on equity is 13.4%, and it has net margins of 8.9%.
Key information
25.2%
Earnings growth rate
24.7%
EPS growth rate
Life Sciences Industry Growth | 36.9% |
Revenue growth rate | 11.8% |
Return on equity | 13.4% |
Net Margin | 8.9% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Siegfried Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 1,271 | 113 | 107 | 43 |
30 Sep 23 | 1,261 | 131 | 75 | 44 |
30 Jun 23 | 1,250 | 149 | 44 | 45 |
31 Mar 23 | 1,240 | 153 | 44 | 44 |
31 Dec 22 | 1,230 | 156 | 43 | 43 |
30 Sep 22 | 1,226 | 143 | 62 | 43 |
30 Jun 22 | 1,222 | 129 | 80 | 42 |
31 Mar 22 | 1,162 | 112 | 73 | 41 |
31 Dec 21 | 1,102 | 96 | 66 | 40 |
30 Sep 21 | 1,013 | 83 | 70 | 38 |
30 Jun 21 | 924 | 69 | 73 | 36 |
31 Mar 21 | 884 | 65 | 70 | 34 |
31 Dec 20 | 845 | 61 | 68 | 31 |
30 Sep 20 | 836 | 52 | 75 | 29 |
30 Jun 20 | 828 | 43 | 83 | 28 |
31 Mar 20 | 831 | 48 | 85 | 30 |
31 Dec 19 | 834 | 53 | 87 | 33 |
30 Sep 19 | 822 | 56 | 72 | 34 |
30 Jun 19 | 811 | 58 | 58 | 34 |
31 Mar 19 | 803 | 57 | 58 | 31 |
31 Dec 18 | 794 | 56 | 58 | 27 |
30 Sep 18 | 786 | 52 | 61 | 27 |
30 Jun 18 | 779 | 49 | 64 | 26 |
31 Mar 18 | 765 | 45 | 61 | 26 |
31 Dec 17 | 750 | 41 | 58 | 26 |
30 Sep 17 | 732 | 38 | 55 | 25 |
30 Jun 17 | 713 | 36 | 52 | 24 |
31 Mar 17 | 716 | 32 | 53 | 23 |
31 Dec 16 | 718 | 28 | 54 | 21 |
30 Sep 16 | 676 | 30 | 53 | 22 |
30 Jun 16 | 633 | 33 | 51 | 23 |
31 Mar 16 | 557 | 36 | 44 | 23 |
31 Dec 15 | 481 | 39 | 37 | 23 |
30 Sep 15 | 416 | 39 | 31 | 22 |
30 Jun 15 | 351 | 40 | 25 | 21 |
31 Mar 15 | 333 | 39 | 25 | 21 |
31 Dec 14 | 315 | 39 | 25 | 21 |
30 Sep 14 | 329 | 46 | 32 | 21 |
30 Jun 14 | 343 | 54 | 38 | 22 |
31 Mar 14 | 359 | 54 | 41 | 22 |
31 Dec 13 | 375 | 54 | 44 | 23 |
30 Sep 13 | 380 | 40 | 47 | 24 |
30 Jun 13 | 386 | 26 | 50 | 24 |
Quality Earnings: 0QQO has high quality earnings.
Growing Profit Margin: 0QQO's current net profit margins (8.9%) are lower than last year (12.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0QQO's earnings have grown significantly by 25.2% per year over the past 5 years.
Accelerating Growth: 0QQO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 0QQO had negative earnings growth (-28%) over the past year, making it difficult to compare to the Life Sciences industry average (6.5%).
Return on Equity
High ROE: 0QQO's Return on Equity (13.4%) is considered low.